DK166541B1 - Fremgangsmaade til isolering af isosilybinfrit silibinin - Google Patents

Fremgangsmaade til isolering af isosilybinfrit silibinin Download PDF

Info

Publication number
DK166541B1
DK166541B1 DK537685A DK537685A DK166541B1 DK 166541 B1 DK166541 B1 DK 166541B1 DK 537685 A DK537685 A DK 537685A DK 537685 A DK537685 A DK 537685A DK 166541 B1 DK166541 B1 DK 166541B1
Authority
DK
Denmark
Prior art keywords
anhydrous
ceph
aminothiazol
acetamido
carboxyprop
Prior art date
Application number
DK537685A
Other languages
Danish (da)
English (en)
Other versions
DK537685D0 (da
DK537685A (da
Inventor
Rolf Madaus
Klaus Goerler
Hartwig Soicke
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of DK537685D0 publication Critical patent/DK537685D0/da
Publication of DK537685A publication Critical patent/DK537685A/da
Application granted granted Critical
Publication of DK166541B1 publication Critical patent/DK166541B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L59/00—Thermal insulation in general
    • F16L59/04—Arrangements using dry fillers, e.g. using slag wool which is added to the object to be insulated by pouring, spreading, spraying or the like

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK537685A 1984-11-22 1985-11-21 Fremgangsmaade til isolering af isosilybinfrit silibinin DK166541B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3442641 1984-11-22
DE3442641 1984-11-22
DE3537656 1985-10-23
DE19853537656 DE3537656A1 (de) 1984-11-22 1985-10-23 Verfahren zur herstellung von isosilybinfreiem silibinin und arzneimittel, enthaltend silibinin

Publications (3)

Publication Number Publication Date
DK537685D0 DK537685D0 (da) 1985-11-21
DK537685A DK537685A (da) 1986-05-23
DK166541B1 true DK166541B1 (da) 1993-06-07

Family

ID=25826741

Family Applications (3)

Application Number Title Priority Date Filing Date
DK537685A DK166541B1 (da) 1984-11-22 1985-11-21 Fremgangsmaade til isolering af isosilybinfrit silibinin
DK189491A DK164866C (da) 1984-11-22 1991-11-20 Fremgangsmaade til isolering af isosilybinfrit silibinin
DK199201145A DK172879B1 (da) 1984-11-22 1992-09-17 Silibininholdigt farmaceutisk præparat

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK189491A DK164866C (da) 1984-11-22 1991-11-20 Fremgangsmaade til isolering af isosilybinfrit silibinin
DK199201145A DK172879B1 (da) 1984-11-22 1992-09-17 Silibininholdigt farmaceutisk præparat

Country Status (26)

Country Link
US (1) US4871763A (xx)
JP (1) JPH0678228B2 (xx)
AR (1) AR241268A1 (xx)
AT (1) AT391315B (xx)
BE (1) BE903694A (xx)
CA (1) CA1337125C (xx)
CH (1) CH660008A5 (xx)
CS (1) CS271321B2 (xx)
DE (1) DE3537656A1 (xx)
DK (3) DK166541B1 (xx)
EG (1) EG17710A (xx)
ES (2) ES8609312A1 (xx)
FI (1) FI84065C (xx)
FR (1) FR2573426B1 (xx)
GB (1) GB2167746B (xx)
HU (1) HU195504B (xx)
IE (1) IE59209B1 (xx)
IT (1) IT1207508B (xx)
LU (1) LU86164A1 (xx)
MX (1) MX172175B (xx)
NL (1) NL192204C (xx)
NO (1) NO160206C (xx)
PL (1) PL146889B1 (xx)
PT (1) PT81531B (xx)
SE (1) SE457957B (xx)
YU (1) YU43690B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
DE4401902C2 (de) * 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
FR2719451B1 (fr) * 1994-05-04 1996-07-26 Apcis Sa Utilisation de la silybinine dans le gavage des palmipèdes, en vue de l'obtention d'un foie gras de meilleure qualité.
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
DE69824223T2 (de) 1997-03-19 2004-09-30 Unilever N.V. Vorrichtung zum Handhaben von Gegenständen
GB2327607B8 (en) * 1997-07-31 2005-03-30 Litton Internat Company Ltd A process for producing a herbal extract composition
DE10053384A1 (de) * 2000-10-27 2002-05-08 Bionorica Arzneimittel Gmbh Pharmazeutische Zubereitung aus Mariendistel und Terpenen
US6699900B2 (en) * 2001-04-07 2004-03-02 Jan E. Zielinski Hydrophilic and lipophilic silibinin pro-forms
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
BG65997B1 (bg) * 2005-03-29 2010-09-30 "Софарма" Ад Метод за получаване на силибинин
ES2374117T3 (es) * 2007-11-15 2012-02-13 Madaus Gmbh Componente de silibinina para el tratamiento de la hepatitis.
CA2761656C (en) 2009-05-14 2017-02-07 Lucio Claudio Rovati Amorphous silibinin for the treatment of viral hepatitis
WO2011051742A1 (en) 2009-10-28 2011-05-05 Modutech S.A. Preparation comprising amino acids and plants and its activity in the alcohol detoxification
CN103408539B (zh) * 2013-08-28 2016-04-06 天津泰阳制药有限公司 高纯度水飞蓟宾的生产方法
CN109071482A (zh) * 2016-01-15 2018-12-21 汉堡大学 携有o-鼠李糖基残基的类黄酮型化合物
US20240024399A1 (en) 2020-09-29 2024-01-25 Munisekhar Medasani Bioactive compounds extraction from plant matters of silybum marianum and usage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923082C3 (de) * 1969-05-06 1985-08-22 Dr. Madaus & Co, 5000 Koeln Verfahren zur Gewinnung von Polyhydroxyphenylchromanonen (Silymarin I-IV) und Arzneimittel enthaltend das Polyhydroxyphenylchromanon (Silymarin I-IV = Silymarin I-IV-Gruppe)Gemisch
US3773932A (en) * 1968-06-01 1973-11-20 Madaus & Co Dr Method for recovering silymarin comprising polyhydroxyphenyl chromanones
DE1767666C3 (de) * 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE2416302B2 (de) * 1974-04-04 1978-02-02 Dr. Madaus & Co, 5000 Köln Dimeres sowie trimeres silybin und deren n-methylglucaminsalz und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
BE885558A (fr) * 1980-10-07 1981-04-07 Madaus & Co Dr Procede pour l'extraction de silymarine a partir des plantes silymarine ainsi obtenue et son utilisation en therapeutique
DE3225688A1 (de) * 1982-07-09 1984-01-12 Suschnik Matthias Dr Verfahren zur gewinnung von silymarin aus silybum marianum

Also Published As

Publication number Publication date
FR2573426B1 (fr) 1988-06-10
AT391315B (de) 1990-09-25
SE8505488D0 (sv) 1985-11-20
CS837985A2 (en) 1990-02-12
FI854536A0 (fi) 1985-11-18
FI84065B (fi) 1991-06-28
YU181285A (en) 1987-12-31
SE8505488L (sv) 1986-05-23
PL256373A1 (en) 1986-12-02
US4871763A (en) 1989-10-03
ES8609312A1 (es) 1986-09-01
PL146889B1 (en) 1989-03-31
DK537685D0 (da) 1985-11-21
HU195504B (en) 1988-05-30
NL192204B (nl) 1996-11-01
GB2167746B (en) 1989-01-11
CA1337125C (en) 1995-09-26
NO160206C (no) 1989-03-22
EG17710A (en) 1990-10-30
DE3537656C2 (xx) 1989-03-16
DK164866C (da) 1993-01-18
BE903694A (fr) 1986-05-22
FI854536A (fi) 1986-05-23
LU86164A1 (de) 1986-03-24
GB2167746A (en) 1986-06-04
GB8527809D0 (en) 1985-12-18
AR241268A1 (es) 1992-04-30
NO160206B (no) 1988-12-12
CH660008A5 (de) 1987-03-13
NL8503136A (nl) 1986-06-16
FI84065C (fi) 1991-10-10
JPH05271071A (ja) 1993-10-19
NO854657L (no) 1986-05-23
ES549119A0 (es) 1986-09-01
FR2573426A1 (fr) 1986-05-23
IE59209B1 (en) 1994-01-26
IT8522933A0 (it) 1985-11-21
IT1207508B (it) 1989-05-25
PT81531B (pt) 1987-11-11
DE3537656A1 (de) 1986-05-22
PT81531A (de) 1985-12-01
ES554022A0 (es) 1987-04-01
SE457957B (sv) 1989-02-13
CS271321B2 (en) 1990-09-12
IE852927L (en) 1986-05-22
DK114592A (da) 1992-09-17
MX172175B (es) 1993-12-07
DK114592D0 (da) 1992-09-17
DK537685A (da) 1986-05-23
DK172879B1 (da) 1999-09-06
DK164866B (da) 1992-08-31
ES8704482A1 (es) 1987-04-01
DK189491A (da) 1991-11-20
HUT40115A (en) 1986-11-28
DK189491D0 (da) 1991-11-20
YU43690B (en) 1989-10-31
JPH0678228B2 (ja) 1994-10-05
ATA337285A (de) 1990-03-15
NL192204C (nl) 1997-03-04

Similar Documents

Publication Publication Date Title
DK166541B1 (da) Fremgangsmaade til isolering af isosilybinfrit silibinin
KR840001776B1 (ko) 세프타지딤 펜타하이드레이트의 제조방법
FI86854B (fi) Foerfarande foer framstaellning av kristallina hydrat av cefalosporinsalt.
CN104130273B (zh) 一种头孢曲松钠的合成方法
CN102180890A (zh) 头孢硫脒水合物及其制备方法和用途
US4624948A (en) Crystalline modification of ceftazidim
DK163514B (da) Fremgangsmaade til fremstilling af en krystallinsk form af natriumsaltet af et oximderivat af 7-aminothiazolylacetamidocephalosporansyre
DK158443B (da) Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre
EP0134568B1 (en) Stable antibacterial lyophilizates
CA1307464C (en) Lyophilized or precipitated cephalosporin zwitterion and salt composition
CS276849B6 (en) Process for preparing heat stable crystalline mono chloride
US3928592A (en) Antibiotic pharmaceutical compositions
JPH01110690A (ja) 水溶性抗生物質組成物および新規セフェム化合物の水溶性塩類
DK152757B (da) Fremgangsmaade til fremstilling af hoejkrystallinsk natriumcefoperazon
JPS603314B2 (ja) セフアロスポリン誘導体およびその製造法
JP2958567B2 (ja) 非経口用凍結乾燥ｂｍｙ―２８１４２ジ塩酸塩
EP0169700B1 (en) Improved pharmaceutical formulations for ceftazidime
JPS636552B2 (xx)
CA1239390A (en) Cefonicid monosodium salt
CA1243297A (en) Crystalline modification of ceftazidim
JP2003514779A5 (xx)
FI83877C (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra
EP0271916B1 (en) Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient
US3258461A (en) Derivatives of cephalosporin c and related compounds and a method of the synthesis thereof
WO2012066492A1 (en) Processes for the preparation of carbapenem antibiotic composition

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed